Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma

Cancer Gene Therapy

Volumn 7, Issue 11, 2000, Pages 1481-1490

  Tanaka, M ^a   Saijo, Y ^a   Sato, G ^a   Suzuki, T ^a   Tazawa, R ^a   Satoh, K ^a   Nukiwa, T ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

IL 12; IL 2; Lewis lung carcinoma; Tumor rejection

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; GENE THERAPY; GENE TRANSFER; GROWTH INHIBITION; IMMUNOLOGICAL MEMORY; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR REJECTION;

ANIMALIA;

EID: 0033674366     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700251     Document Type: Article

References (33)

1. Gene therapy for cancer: What have we done and where are we going?
2. Combined chemokine and cytokine gene transfer enhances antitumor immunity
3. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
4. Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
5. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector
6. Combination effect of vaccination with IL-2 and IL-4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells
7. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice
8. Characterization of a factor(s) which synergizes with recombinant interleukin-2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro
9. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells
10. Induction of interferon-γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
11. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
12. CD2 regulates responsiveness of activated T cells to interleukin-12
13. Regulation of human cytolytic lymphocyte responses by interleukin-12
14. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production
15. B7-1 and interleukin-12 synergistically induce effective antitumor immunity
16. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
17. Interleukin-12 and its role in generation of T(H)1 cells
18. + T cells through IL-12 produced by Listeria-induced macrophages
19. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2
20. Interleukin-2 toxicity
21. IL-12 Deaths: Explanation and a puzzle
22. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
23. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12
24. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
25. Effect of angiogenesis inhibitors on multistage carcinogenesis in mice
26. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NK T cells
27. +NK T cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system
28. Exogenous recombinant human IL-12 augments MHC class I antigen expression on human cancer cells in vitro
29. Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors
30. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-γ cDNAs
31. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells
32. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness
33. Tumor-targeted IL-2 amplifies T-cell-mediated immune response induced by gene therapy with single-chain IL-12